[1]
|
Grubb, B.P. and McMann, M.C. (2001) The fainting phenomenon: Understanding why people faint and what can be done about it. Futura, New York.
|
[2]
|
Neurocardiogenic syncope (2011).
http://www.dinet.org/NCS/ncs.htm
|
[3]
|
Savage, D.D., Corwin, L., McGee, D.L., Kannel, W.B. and Wolf, P.A. (1985) Epidemiologic features of isolated syncope: The Framingham Study. Stroke, 16, 626-629.
doi:10.1161/01.STR.16.4.626
|
[4]
|
Chen, L., Chen, M.H., Larson, M.G., Evans, J., Benjamin, E.J. and Levy, D. (2000) Risk factors for syncope in a community based sample (the framingham heart study). American Journal of Cardiology, 85, 1189-1193.
doi:10.1016/S0002-9149(00)00726-8
|
[5]
|
Deering, A (2007) Cheltenham syncope clinic.
http://www.sycope.co.uk/
|
[6]
|
Alboni, P., Brignole, M., Menozzi, C., Raviele, A., DelRosso, A., Dinelli, M., Soluno, A. and Bottoni, N. (2001) Diagnostic value of history in patients with syncope with or without heart disease. Journal of American College of Cardiology, 37, 1921-1928.
doi:10.1016/S0735-1097(01)01241-4
|
[7]
|
Aydin, M.A., Maas, R., Mortensen, K., Steinig, T., Kleem, H., Risius, T., Meinertz, T., Willems, S., Morillo, C.A. and Ventura, R. (2008) Predicting recurrence of vasovagal syncope: A simple risk score for the clinical routine. Journal of Cardiovascular Electrophysiology, 20, 416-421. doi:10.1111/j.1540-8167.2008.01352.x
|
[8]
|
Kuriachan, V., Sheldon, R.S. and Platonov, M. (2008) Evidence-based treatment for vasovagal syncope. Heart Rhythm, 5, 1609-1614.
doi:10.1016/j.hrthm.2008.08.023
|
[9]
|
Bolles, J.A., Gentlesk, P.J., Lewis, P.C., Ross, R.D. and Eckart, R.E. (2010) Resource utilization in the management of young patients with syncope in a combat theater of operations. Military Medicine, 175, 324-327.
|
[10]
|
Linzer, M., Pontinon, M. and Gold, D.T. (1991) Impairment of physical and psychosocial health in recurrent syncope. Journal of Clinical Epidemiology, 44, 1037-1043. doi:10.1016/0895-4356(91)90005-T
|
[11]
|
Di Girolamo, E., Di Iorio, C., Sabatini, P., Leonzio, L., Barbone, C. and Barsotti, A. (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-bind, placebo-controlled study. Journal of the American College of Cardiology, 33, 1227-1230.
doi:10.1016/S0735-1097(98)00694-9
|
[12]
|
Di Girolamo, E., Di Iorio, C., Leonzio, L., Sabatini, P., Ranalli, G. and Barsotti, A. (1999) Effects of paroxetine in the treatment of refractory vasovagal syncope in young patients. Giornale Italiano Di Cardiologia, 29, 1472-1477.
|
[13]
|
Foglia-Manzillo, G., Giada, Fr., Gaggioli, G., et al. (2004) Effacacy of tilt training in the treatment of neutrallymediated syncope. A randomized study. Europace, 6, 199-204. doi:10.1016/j.eupc.2004.01.002
|
[14]
|
D’Antono, B.D., Dupuis, G., St-Jean, K., Levesque, K., Nadeau, R., Guerra, P., Thibault, B. and Kus, T. (2009) Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope. Journal of Psychosomatic Research, 67, 213-222. doi:10.1016/j.jpsychores.2009.03.012
|
[15]
|
Gracie, J., Newton, J. L., Norton, M., Baker, C. and Reeston, M. (2006) The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope. Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiace Cellular Electrophysiology of the European Society of Cardiology, 8, 636-643.
doi:10.1093/europace/eul073
|
[16]
|
Kiecolt-Glaser, J.K. (2010) Stress, food, and inflamemation: Psychoneuroimmunology and nutrition at the cutting edge. Psychosomatic Medicine, 72, 365-369.
doi:10.1097/PSY.0b013e3181dbf489
|
[17]
|
Takata, T.S., Wasmund, S.L., Smith, M.L., Li, J.M., Joglar, J.A., Banks, K., Kowal, R.C., Page, R.L. and Hamdan, M.H. (2002) Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation, 106, 1500-1504. doi:10.1161/01.CIR.0000029748.94931.96
|
[18]
|
Linzer, M., Varia, I., Pontinen, M., et al. (1992) Medically unexplained syncope: Relationship to psychiatry illness. American Journal of Medicine, 92, S18-S25.
doi:10.1016/0002-9343(92)90132-U
|
[19]
|
Keller, M.B., McCullough, J.P., Klein, D.N., et al. (2002). A comparison of nefrzodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462-1470.
doi:10.1056/NEJM200005183422001
|